CoChat
Cited by 200

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer

Open access
Chen, Ping, Zhang, Xu, Ding, Renbo, Yang, Linglin, Lyu, Xueying, Zeng, Jianming, Lei, Josh Haipeng, Wang, Lijian, Bi, Jiong, Shao, Nan, Shu, Ditian, Wu, Bin, Wu, Jingbo, Yang, Zhihui, Wang, Haiyan, Wang, Biqiong, Xiong, Kang, Lu, Yun, Fu, Shaozhi, Choi, Tak Kan, Lon, Ng Wai, Zhang, Aiping, Tang, Dongyang, Quan, Yingyao, Meng, Ya, Miao, Kai, Sun, Heng, Zhao, Ming, Bao, Jiaolin, Zhang, Lei, Xu, Xiaoling, Shi, Yanxia, Lin, Ying, Deng, Chuxia · 2021 · Advanced Science

Abstract

Most breast cancers at an advanced stage exhibit an aggressive nature, and there is a lack of effective anticancer options. Herein, the development of patient‐derived organoids (PDOs) is described as a real‐time platform to explore the feasibility of tailored treatment for refractory breast cancers. PDOs are successfully generated from breast cancer tissues, including heavily treated specimens. The microtubule‐targeting drug‐sensitive response signatures of PDOs predict improved distant relapse‐free survival for invasive breast cancers treated with adjuvant chemotherapy. It is further demonstrated that PDO pharmaco‐phenotyping reflects the previous treatment responses of the corresponding patients. Finally, as clinical case studies, all patients who receive at least one drug predicate to be sensitive by PDOs achieve good responses. Altogether, the PDO model is developed as an effective platform for evaluating patient‐specific drug sensitivity in vitro, which can guide personal treatment decisions for breast cancer patients at terminal stage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202101176

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 200

Metadata

Authors
Chen, P., Zhang, X., Ding, R., Yang, L., Lyu, X., Zeng, J., Lei, J. H., Wang, L., Bi, J., Shao, N., Shu, D., Wu, B., Wu, J., Yang, Z., Wang, H., Wang, B., Xiong, K., Lu, Y., Fu, S., Choi, T. K., Lon, N. W., Zhang, A., Tang, D., Quan, Y., Meng, Y., Miao, K., Sun, H., Zhao, M., Bao, J., Zhang, L., Xu, X., Shi, Y., Lin, Y., & Deng, C.
Venue
Advanced Science
Publisher
Wiley
Published
2021-10-04
Volume
8
Issue
22
Pages
e2101176-e2101176
ISSN
2198-3844 (ISSN-L)
OpenAlex
W3202739872
Cited by
200
References
21
FWCI
7.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer. https://app.cochat.ai/papers/10.1002/advs.202101176
The paper
Chen, P., Zhang, X., Ding, R., Yang, L., Lyu, X., Zeng, J., Lei, J. H., Wang, L., Bi, J., Shao, N., Shu, D., Wu, B., Wu, J., Yang, Z., Wang, H., Wang, B., Xiong, K., Lu, Y., Fu, S., . . . Deng, C. (2021). Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer. Advanced Science. https://doi.org/10.1002/advs.202101176

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.